表紙：ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測：2020年～2027年

市場調査レポート

商品コード

1027061

ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測：2020年～2027年

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日: 2021年08月01日 | 発行:

Value Market Research | ページ情報: 英文 210 Pages | 納期: 即日から翌営業日

AI翻訳ツール提供対象

ご購入後の翻訳ツール提供について

価格

Data Pack (Single User License)

USD 2,100 273,609円

Excelを1名のみがご利用頂けるライセンスです。Excelの印刷も可能です。印刷したもののご利用はExcelのご利用範囲に準拠します。

PDF (Single User License)

USD 3,950 514,645円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (10-user License)

USD 4,950 644,935円

レポートPDFを同一企業内の10名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate User License)

USD 8,600 1,120,494円

レポートPDFを同一企業のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=130.29円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のヒトマイクロバイオーム市場は、過去数年間で著しい成長を遂げ、2021年～2027年の予測期間中に大幅な成長が予想されています。

当レポートでは、世界のヒトマイクロバイオーム市場について調査分析し、市場促進要因・抑制要因・課題・機会のほか、収益に関する市場の発展について、体系的な情報を提供しています。

企業シェア分析
市場集中度
Embion Technologies SA
ENTEROME SA
Evelo Biosciences Inc.
IGEN BIOLAB GROUP
4D Pharma Plc.
Ferring Pharmaceuticals
Gnubiotics Sciences
YSOPIA Bioscience
ViThera Pharmaceuticals Inc.
Gnubiotics Sciences
Osel Inc.
SECOND GENOME THERAPEUTICS
Immuron Ltd.
OxThera AB
AOBiome
Vedanta Biosciences Inc.

図表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
COVID-19 Impact Analysis by Production, Import, Export and Demand
Pre V/S Post COVID-19
Estimated Impact Of The Coronavirus (Covid-19) Epidemic
COVID-19: Micro and Macro Factor Analysis
Analysis by Product (USD MN)
Probiotics Market by Geography (USD MN)
Prebiotics Market by Geography (USD MN)
Diagnostic Tests Market by Geography (USD MN)
Drugs Market by Geography (USD MN)
Other Products Market by Geography (USD MN)
Analysis Market by Disease (USD MN)
Infectious Diseases Market by Geography (USD MN)
Endocrine and Metabolic Disorders Market by Geography (USD MN)
Gastrointestinal Diseases Market by Geography (USD MN)
Cancer Market by Geography (USD MN)
Other Diseases Market by Geography (USD MN)
Analysis by Application (USD MN)
Therapeutics Market by Geography (USD MN)
Diagnostics Market by Geography (USD MN)
Analysis by Technology (USD MN)
Genomics Market by Geography (USD MN)
Proteomics Market by Geography (USD MN)
Metabolomics Market by Geography (USD MN)
Global Human Microbiome Market by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisiton

LIST OF FIGURES

Research Scope of Human Microbiome Report
Market Research Process
Market Research Methodology
Global Human Microbiome Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Disease
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Technology
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product (USD MN)
Probiotics Market by Geography (USD MN)
Prebiotics Market by Geography (USD MN)
Diagnostic Tests Market by Geography (USD MN)
Drugs Market by Geography (USD MN)
Other Products Market by Geography (USD MN)
Global Market Analysis by Disease (USD MN)
Infectious Diseases Market by Geography (USD MN)
Endocrine and Metabolic Disorders Market by Geography (USD MN)
Gastrointestinal Diseases Market by Geography (USD MN)
Cancer Market by Geography (USD MN)
Other Diseases Market by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Therapeutics Market by Geography (USD MN)
Diagnostics Market by Geography (USD MN)
Global Market Analysis by Technology (USD MN)
Genomics Market by Geography (USD MN)
Proteomics Market by Geography (USD MN)
Metabolomics Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis, 2020

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Product Code: VMR11215790

Value Market Research's latest report on the Global Human Microbiome Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global human microbiome market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global human microbiome market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global human microbiome market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global human microbiome market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global human microbiome market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global human microbiome market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global human microbiome market.

The market analysis involves a section exclusively to list the major players of the global human microbiome market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Human Microbiome Market Report Segments the market as below:

By Product

Probiotics
Prebiotics
Diagnostic Tests
Drugs
Other Products

By Disease

Infectious Diseases
Endocrine and Metabolic Disorders
Gastrointestinal Diseases
Cancer
Other Diseases (Cardiovascular Diseases, Neurological Disorders, Dermatology Diseases, Immune-Modulated Disorders, and Hematological Disorders.)

By Application

Therapeutics
Diagnostics

By Technology Type

Genomics

Sequencing
- 16s rRNA sequencing method
- Whole-genome sequencing method
- Other Sequencing methods (shotgun metagenomic sequencing, transcriptomics, and targeted sequencing.)

Other Genomic Technologies (Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and DNA Microarrays)
- Proteomics
- Metabolomics

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HUMAN MICROBIOME - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Product
- 3.7.2 By Disease
- 3.7.3 By Application
- 3.7.4 By Technology
- 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Probiotics Market by Regions
6.5 Prebiotics Market by Regions
6.6 Diagnostic Tests Market by Regions
6.7 Drugs Market by Regions
6.8 Other Products Market by Regions

7 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY DISEASE

7.1 Overview by Disease
7.2 Historical and Forecast Data
7.3 Analysis by Disease
7.4 Infectious Diseases Market by Regions
7.5 Endocrine and Metabolic Disorders Market by Regions
7.6 Gastrointestinal Diseases Market by Regions
7.7 Cancer Market by Regions
7.8 Other Diseases Market by Regions

8 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Therapeutics Market by Regions
8.5 Diagnostics Market by Regions

9 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY TECHNOLOGY

9.1 Overview by Technology
9.2 Historical and Forecast Data
9.3 Analysis by Technology
9.4 Genomics Market by Regions
9.5 Proteomics Market by Regions
9.6 Metabolomics Market by Regions

10 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America
- 10.3.1. Overview, Historic and Forecast Data
- 10.3.2. North America By Segment
- 10.3.3. North America By Country
- 10.3.4. United State
- 10.3.5. Canada
- 10.3.6. Mexico
10.4. Europe
- 10.4.1. Overview, Historic and Forecast Data
- 10.4.2. Europe by Segment
- 10.4.3. Europe by Country
- 10.4.4. United Kingdom
- 10.4.5. France
- 10.4.6. Germany
- 10.4.7. Italy
- 10.4.8. Russia
- 10.4.9. Rest Of Europe
10.5. Asia Pacific
- 10.5.1. Overview, Historic and Forecast Data
- 10.5.2. Asia Pacific by Segment
- 10.5.3. Asia Pacific by Country
- 10.5.4. China
- 10.5.5. India
- 10.5.6. Japan
- 10.5.7. South Korea
- 10.5.8. Australia
- 10.5.9. Rest Of Asia Pacific
10.6. Latin America
- 10.6.1. Overview, Historic and Forecast Data
- 10.6.2. Latin America by Segment
- 10.6.3. Latin America by Country
- 10.6.4. Brazil
- 10.6.5. Argentina
- 10.6.6. Peru
- 10.6.7. Chile
- 10.6.8. Rest of Latin America
10.7. Middle East & Africa
- 10.7.1. Overview, Historic and Forecast Data
- 10.7.2. Middle East & Africa by Segment
- 10.7.3. Middle East & Africa by Country
- 10.7.4. Saudi Arabia
- 10.7.5. UAE
- 10.7.6. Israel
- 10.7.7. South Africa
- 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE HUMAN MICROBIOME COMPANIES

11.1. Human Microbiome Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF HUMAN MICROBIOME INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Embion Technologies S.A
- 12.3.1. Company Overview
- 12.3.2. Financials
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. ENTEROME SA
- 12.4.1. Company Overview
- 12.4.2. Financials
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Evelo Biosciences Inc.
- 12.5.1. Company Overview
- 12.5.2. Financials
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. IGEN BIOLAB GROUP
- 12.6.1. Company Overview
- 12.6.2. Financials
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. 4D Pharma Plc.
- 12.7.1. Company Overview
- 12.7.2. Financials
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Ferring Pharmaceuticals
- 12.8.1. Company Overview
- 12.8.2. Financials
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Gnubiotics Sciences
- 12.9.1. Company Overview
- 12.9.2. Financials
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. YSOPIA Bioscience
- 12.10.1. Company Overview
- 12.10.2. Financials
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. ViThera Pharmaceuticals Inc.
- 12.11.1. Company Overview
- 12.11.2. Financials
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Gnubiotics Sciences
- 12.12.1. Company Overview
- 12.12.2. Financials
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Osel Inc.
- 12.13.1. Company Overview
- 12.13.2. Financials
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. SECOND GENOME THERAPEUTICS
- 12.14.1. Company Overview
- 12.14.2. Financials
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. Immuron Ltd.
- 12.15.1. Company Overview
- 12.15.2. Financials
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. OxThera AB
- 12.16.1. Company Overview
- 12.16.2. Financials
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. AOBiome
- 12.17.1. Company Overview
- 12.17.2. Financials
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Vedanta Biosciences Inc.
- 12.18.1. Company Overview
- 12.18.2. Financials
- 12.18.3. Products
- 12.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測：2020年～2027年

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

目次

第1章序文

第2章エグゼクティブサマリー

第3章ヒトマイクロバイオーム：業界分析

第4章バリューチェーン分析

第5章 COVID-19アウトブレイクの影響分析

第6章世界のヒトマイクロバイオーム市場分析：製品別

第7章世界のヒトマイクロバイオーム市場分析：疾患別

第8章世界のヒトマイクロバイオーム市場分析：用途別

第9章世界のヒトマイクロバイオーム市場分析：技術別

第10章世界のヒトマイクロバイオーム市場分析：地域別

第11章ヒトマイクロバイオーム企業の競合情勢

第12章企業プロファイル